men, especially the older men, had become dormant at some point in their development. But dormant or not, had these men been biopsied while alive, their Gleason scores could very well have led to what we know in hindsight to have been unnecessary treatments.
Active surveillance programs are intended to reduce or delay the number of treatments offered to men suspected of harboring prostate cancer. There are no hard and fast rules for active surveillance programs; they are mainly intended for men whose Gleason scores are 6 or lower, and whose DREs or ultrasound scans are ambiguous. PSA levels play an important role in surveillance programs as rising levels over a period of months suggest developing disease. When this happens, biopsies are recommended to determine whether there is a corresponding increase in the patient's Gleason score.
I trust that this letter will spur other physicists who have unique knowledge of, or experience with, an aspect of cancer that would be of interest to other physicists to write similar summaries.
